Oligometastatic Clinical Trials in Baltimore, Maryland
3 recruitingBaltimore, Maryland
Showing 1–3 of 3 trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled142 locationsNCT05939414
Recruiting
Phase 2
TERPS Trial for de Novo Oligometastic Prostate Cancer
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore122 enrolled9 locationsNCT05223803
Recruiting
Phase 2
High-Risk Metachronous Oligometastatic Prostate Cancer Trial
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore88 enrolled1 locationNCT06212583